Salcatonin
Overview
Categories
- 18 Hormones and other endocrine drugs and contraceptives
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Di-Isopromine (HCl)'s dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 4 IU/kg | 4 (4) | 12 hourly | SC/IM | For hypercalcemia: If the response to this dosage is not satisfactory after 1 to 2 days, dosage may be increased up to 8 IU/kg every 12 hours. If there is no satisfactory improvement after another 2 days, dosage may be increased to a maximum of 8 IU/kg every 6 hours. |
| 100 IU | 100 (100) | 24 hourly | SC/IM | For paget''s disease |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Di-Isopromine (HCl) is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Di-Isopromine (HCl) is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Di-Isopromine (HCl)
Back to top
Previous Drug Generic - Next Drug Generic